BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Zhong-Liang Su, Chien-Wei Su, Yi-Luen Huang, Wan-Yu Yang, Bonifasius Putera Sampurna, Toru Ouchi, Kuan-Lin Lee, Chen-Sheng Wu, Horng-Dar Wang, Chiou-Hwa Yuh. A Novel AURKA Mutant-Induced Early-Onset Severe Hepatocarcinogenesis Greater than Wild-Type via Activating Different Pathways in ZebrafishCancers 2019; 11(7): 927 doi: 10.3390/cancers11070927
2
Zhen Wang, Yan-Jiang Han, Shun Huang, Meng Wang, Wen-Lan Zhou, Hong-Sheng Li, Quan-Shi Wang, Hu-Bing Wu. Imaging the expression of glypican-3 in hepatocellular carcinoma by PETAmino Acids 2018; 50(2): 309 doi: 10.1007/s00726-017-2517-z
3
Mamdouh M Ali, Ibrahim H Borai, Hala M Ghanem, Abeer H Abdel-Halim, Fatma M Mousa. The prophylactic and therapeutic effects of Momordica charantia methanol extract through controlling different hallmarks of the hepatocarcinogenesisBiomedicine & Pharmacotherapy 2018; 98: 491 doi: 10.1016/j.biopha.2017.12.096
4
Wan-Yu Yang, Pei-Shu Rao, Yong-Chun Luo, Hua-Kuo Lin, Sing-Han Huang, Jinn-Moon Yang, Chiou-Hwa Yuh. Omics-based Investigation of Diet-induced Obesity Synergized with HBx, Src, and p53 Mutation Accelerating Hepatocarcinogenesis in Zebrafish ModelCancers 2019; 11(12): 1899 doi: 10.3390/cancers11121899
5
Preedia Babu Ezhuthupurakkal, Subastri Ariraman, Suyavaran Arumugam, Nithyananthan Subramaniyan, Suresh Kumar Muthuvel, Premkumar Kumpati, Bharathidasan Rajamani, Thirunavukkarasu Chinnasamy. Anticancer potential of ZnO nanoparticle-ferulic acid conjugate on Huh-7 and HepG2 cells and diethyl nitrosamine induced hepatocellular cancer on Wistar albino ratNanomedicine: Nanotechnology, Biology and Medicine 2018; 14(2): 415 doi: 10.1016/j.nano.2017.11.003
6
Zhou-wei Xu, Shang-xue Yan, Hua-xun Wu, Ying Zhang, Wei Wei. Angiotensin II and tumor necrosis factor-α stimulate the growth, migration and invasion of BEL-7402 cells via down-regulation of GRK2 expressionDigestive and Liver Disease 2019; 51(2): 263 doi: 10.1016/j.dld.2018.06.007
7
Yan Chen, Jiongshan Zhang, Mengting Liu, Zengcheng Zou, Fenglin Wang, Hao Hu, Baoguo Sun, Shijun Zhang. Risk of Developing Hepatocellular Carcinoma following Depressive Disorder Based on the Expression Level of Oatp2a1 and Oatp2b1BioMed Research International 2019; 2019: 1 doi: 10.1155/2019/3617129
8
Hanan Omar, Samaa Taha, Wafaa Hassan, Hamdy Omar. Occult hepatitis B infection: a hidden factor of poor response to intervention treatment of hepatocellular carcinoma in chronic hepatitis C patientsComparative Clinical Pathology 2018; 27(5): 1273 doi: 10.1007/s00580-018-2735-0
9
Keita Fukuyama, Masataka Asagiri, Masahiro Sugimoto, Hiraki Tsushima, Satoru Seo, Kojiro Taura, Shinji Uemoto, Keiko Iwaisako, Matias A Avila. Gene expression profiles of liver cancer cell lines reveal two hepatocyte-like and fibroblast-like clustersPLOS ONE 2021; 16(2): e0245939 doi: 10.1371/journal.pone.0245939
10
I. Walter, U. Schulz, M. Vogelhuber, K. Wiedmann, E. Endlicher, F. Klebl, R. Andreesen, W. Herr, L. Ghibelli, C. Hackl, R. Wiest, A. Reichle. Communicative reprogramming non-curative hepatocellular carcinoma with low-dose metronomic chemotherapy, COX-2 inhibitor and PPAR-gamma agonist: a phase II trialMedical Oncology 2017; 34(12) doi: 10.1007/s12032-017-1040-0
11
María Paula Ceballos, Juan Pablo Rigalli, Lucila Inés Ceré, Mariana Semeniuk, Viviana Alicia Catania, María Laura Ruiz. ABC Transporters: Regulation and Association with Multidrug Resistance in Hepatocellular Carcinoma and Colorectal CarcinomaCurrent Medicinal Chemistry 2019; 26(7): 1224 doi: 10.2174/0929867325666180105103637
12
BaoChun Wang, Jian Xu, HaiYang Wang, ShunWu Chang, Ning Liu. Effect and Mechanism of Sophoridine to suppress Hepatocellular carcinoma in vitro and vivoBiomedicine & Pharmacotherapy 2017; 95: 324 doi: 10.1016/j.biopha.2017.08.029
13
Rasha R. Radwan, Hussein E. Ali. Radiation-synthesis of chitosan/poly (acrylic acid) nanogel for improving the antitumor potential of rutin in hepatocellular carcinomaDrug Delivery and Translational Research 2021; 11(1): 261 doi: 10.1007/s13346-020-00792-7
14
Nithyananthan Subramaniyam, Suyavaran Arumugam, Preedia Babu Ezthupurakkal, Subastri Ariraman, Indrani Biswas, Suresh Kumar Muthuvel, Aristatile Balakrishnan, Ghedeir M. Alshammari, Thirunavukkarasu Chinnasamy. Unveiling anticancer potential of glibenclamide: Its synergistic cytotoxicity with doxorubicin on cancer cellsJournal of Pharmaceutical and Biomedical Analysis 2018; 154: 294 doi: 10.1016/j.jpba.2018.03.025
15
Linh Nguyen, Sunny Chapel, Benjamin Duy Tran, Steven Lacy. Cabozantinib exposure–response analyses of efficacy and safety in patients with advanced hepatocellular carcinomaJournal of Pharmacokinetics and Pharmacodynamics 2019; 46(6): 577 doi: 10.1007/s10928-019-09659-y
16
Kaustav Dutta Chowdhury, Avik Sarkar, Sujan Chatterjee, Debajyoti Patra, Dipanwita Sengupta, Soumi Banerjee, Pratip Chakraborty, Gobinda Chandra Sadhukhan. Cathepsin B mediated scramblase activation triggers cytotoxicity and cell cycle arrest by andrographolide to overcome cellular resistance in cisplatin resistant human hepatocellular carcinoma HepG2 cellsEnvironmental Toxicology and Pharmacology 2019; 68: 120 doi: 10.1016/j.etap.2019.03.003
17
Ya Li, Qiuju Han, Huajun Zhao, Quanjuan Guo, Jian Zhang. Napabucasin Reduces Cancer Stem Cell Characteristics in Hepatocellular CarcinomaFrontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.597520
18
Shukui Qin, Richard S Finn, Masatoshi Kudo, Tim Meyer, Arndt Vogel, Michel Ducreux, Teresa Mercade Macarulla, Gianluca Tomasello, Frederic Boisserie, Jeannie Hou, Xin Li, James Song, Andrew X Zhu. RATIONALE 301 study: tislelizumab versus sorafenib as first-line treatment for unresectable hepatocellular carcinomaFuture Oncology 2019; 15(16): 1811 doi: 10.2217/fon-2019-0097
19
Aakash Desai, Sonia Sandhu, Jin-Ping Lai, Dalbir Singh Sandhu. Hepatocellular carcinoma in non-cirrhotic liver: A comprehensive reviewWorld Journal of Hepatology 2019; 11(1): 1-18 doi: 10.4254/wjh.v11.i1.1